+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Colon Cancer Drugs Market Research Reports

From
From
From
From
From
Rectal Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Rectal Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 245 Pages
  • Global
From
Familial Adenomatous Polyposis - Pipeline Review, H2 2020 - Product Thumbnail Image

Familial Adenomatous Polyposis - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 71 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Colon Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat colon cancer. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy drugs are used to kill cancer cells and stop them from growing. Targeted therapy drugs are designed to target specific cancer cells and block their growth. Immunotherapy drugs are used to boost the body’s natural immune system to fight cancer cells. Some of the major companies in the Colon Cancer Drugs market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Eli Lilly. These companies are involved in the research, development, and marketing of drugs used to treat colon cancer. Show Less Read more